Loading stock data…
Streamex Corp. (STEX)
$0.71-0.01 (-1.26%)
Market ClosedLast close Sep 8
Streamex Corp., a medical device technology company, provides advanced digital signal processing solutions for electrophysiology in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Streamex Corp. in the Financial Services sector is trading at $0.71 with a market capitalization of $159M. Wall Street consensus targets $4.00 (1 analysts), implying a +466.6% move over the next 12 months. The stock is currently near its 52-week low of $0.66, remaining 62.0% below its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 45/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +466.6% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -$35.75M↑ | -$41.63M↓ | -$6.11M↑ | -$20.36M↓ | -$2.98M |
| Net Income | -$46.69M↑ | -$424.01M↓ | -$15.58M↑ | -$20.37M↓ | -$2.81M |
Peer Comparison
JPMBACGS
Fundamentals
Streamex Corp., a medical device technology company, provides advanced digital signal processing solutions for electrophysiology in the United States. The company offers the PURE EP platform, which delivers cardiac signal data to electrophysiologists...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$159.23M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
2.01
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-343.70%
Volume
Today's trading volume
986,285
Recent News
Streamex (STEX) Stock Fair Value Moves Lower After Slower GLDY Uptake And Softer Q2
Streamex is back in focus after analysts reset the price target from US$8 to US$4, alongside a new fair value estimate that now sits at the same level. The shift reflects updated views on slower GLDY adoption, softer Q2 profitability and a different balance between growth ambitions and cash burn control. As you read on, you will see how the bullish and bearish arguments are evolving and how to track this changing narrative over time. Stay updated as the Fair Value for Streamex shifts by...
Streamex Corp (STEX) (Q2 2026) Earnings Call Highlights: First Gold Lease Revenue and Path to ...
Streamex Corp (STEX) narrows net loss by 69% while positioning for growth with GLDC launch and institutional partnerships.
Biosig Technologies Q2 Earnings Call Highlights
Biosig Technologies (NASDAQ:STEX) provided a second-quarter update on its Streamex tokenization platform, reporting its first gold lease income while outlining plans to expand distribution for its yield-bearing gold token, GLDY, and launch a permissionless token, GLDC. Chief Executive Officer and c
Streamex Corp. Q2 2026 Earnings Call Summary
Moby summary of Streamex Corp.'s Q2 2026 earnings call
Streamex (NasdaqCM:STEX) Stock Fair Value Falls As GLDY Rollout Concerns Temper Partnership Optimism
Analysts have revised their fair value estimate for Streamex from US$12 to US$8. Recent commentary links this change to slower than hoped GLDY traction and a mixed read through from new partnership announcements, which has led analysts to recalibrate how quickly the company’s roadmap might translate into financial results. Read on to see how this updated price target fits into the evolving Streamex story and how you can track future changes in the narrative. Analyst Price Targets don't always...